Evidence map›Paper›PMID 28794827›Full record

ArticleWorld journal of radiology2017

Preoperative [18]fluorodeoxyglucose-positron emission tomography/computed tomography in early stage breast cancer: Rates of distant metastases.

Vincent Vinh-Hung, Hendrik Everaert, Karim Farid, Navid Djassemi, Jacqueline Baudin-Veronique, Stefanos Bougas, Yuriy Michailovich, Clarisse Joachim-Contaret, Elsa Cécilia-Joseph, Claire Verschraegen and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of radiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vincent Vinh-HungVincent Vinh-Hung, Stefanos Bougas, Department of Radiation Oncology, University Hospital of Martinique, Fort-de-France 97200, Martinique.
Hendrik EveraertVincent Vinh-Hung, Stefanos Bougas, Department of Radiation Oncology, University Hospital of Martinique, Fort-de-France 97200, Martinique.
Karim FaridVincent Vinh-Hung, Stefanos Bougas, Department of Radiation Oncology, University Hospital of Martinique, Fort-de-France 97200, Martinique.
Navid DjassemiVincent Vinh-Hung, Stefanos Bougas, Department of Radiation Oncology, University Hospital of Martinique, Fort-de-France 97200, Martinique.
Jacqueline Baudin-VeroniqueVincent Vinh-Hung, Stefanos Bougas, Department of Radiation Oncology, University Hospital of Martinique, Fort-de-France 97200, Martinique.
Stefanos BougasVincent Vinh-Hung, Stefanos Bougas, Department of Radiation Oncology, University Hospital of Martinique, Fort-de-France 97200, Martinique.
Yuriy MichailovichVincent Vinh-Hung, Stefanos Bougas, Department of Radiation Oncology, University Hospital of Martinique, Fort-de-France 97200, Martinique.
Clarisse Joachim-ContaretVincent Vinh-Hung, Stefanos Bougas, Department of Radiation Oncology, University Hospital of Martinique, Fort-de-France 97200, Martinique.
Elsa Cécilia-JosephVincent Vinh-Hung, Stefanos Bougas, Department of Radiation Oncology, University Hospital of Martinique, Fort-de-France 97200, Martinique.
Claire VerschraegenVincent Vinh-Hung, Stefanos Bougas, Department of Radiation Oncology, University Hospital of Martinique, Fort-de-France 97200, Martinique.
Nam P NguyenVincent Vinh-Hung, Stefanos Bougas, Department of Radiation Oncology, University Hospital of Martinique, Fort-de-France 97200, Martinique.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate rates of distant metastases (DM) detected with [18]fluorodeoxyglucose-positron emission tomography/computed tomography (

methodsWe searched the English language literature databases of PubMed, EMBASE, ISI Web of Knowledge, Web of Science and Google Scholar, for publications on DM detected in patients who had

resultsAmong the 18 total studies included in the analysis, the risk of DM ranged from 0% to 8.3% and 0% to 12.9% for stage I and II invasive breast cancer, respectively. Among the patients with clinical stage II, the rate of occult metastases diagnosed by

conclusionYoung patients with poorly differentiated tumors and stage IIB triple-negative breast cancer may benefit from

Indexed as

[18]fluorodeoxyglucose-positron emission tomography/computed tomography scanBreast cancerDistant metastasesEarly stageStaging workup

Identifiers

PMID28794827
PMCPMC5529320

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.